Advanced Enzyme Technologies Ltd

Advanced Enzyme Technologies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 27 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 31 May 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Advanced Enzyme Technologies Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators across multiple timeframes. The company’s stock, currently trading at ₹387.90, has seen a positive day change of 0.57%, reflecting growing investor confidence amid improving technical signals and a recent upgrade in its Mojo Grade from Sell to Hold.

The 50-day moving average has crossed above the 200-day moving average for Advanced Enzyme Technologies Ltd, signalling a golden cross on 20 May 2026. While this technical event often suggests a shift towards bullish momentum, the broader technical and fundamental context presents a nuanced picture that merits closer examination.

Advanced Enzyme Technologies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 27 Apr 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 20 May 2026, providing investors with the latest insights into its performance and outlook.

With a decisive surge to Rs 412.5 on 11 May 2026, Advanced Enzyme Technologies Ltd has reached a fresh 52-week high, marking a 42.79% gain over the past year. This rally stands out amid a broadly declining Sensex, which has slipped 3.94% over the same period, underscoring the stock’s robust price momentum and technical strength.

Advanced Enzyme Technologies Ltd witnessed a robust start to trading on 11 May 2026, opening with a significant gap up that reflected positive market sentiment. The stock surged 5.51% at the opening bell, setting a new 52-week high of Rs.412.5 and outperforming its sector by 12.79% amid heightened volatility and sustained momentum throughout the day.

While the Sensex declined by 1.06% on 11 May 2026, Advanced Enzyme Technologies Ltd surged 13.35%, reaching an intraday high of Rs 412.5. This remarkable 12.86 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers highlights a distinctly stock-specific rally in an otherwise weak market environment.

Advanced Enzyme Technologies Ltd., India's largest enzyme manufacturer, delivered a strong finish to FY26 with consolidated net profit surging 62.24% year-on-year to ₹42.96 crores in Q4 FY26, up from ₹26.48 crores in the corresponding quarter last year. The ₹4,102 crore market capitalisation company reported quarterly revenues of ₹203.37 crores, marking a 21.65% YoY growth and an 18.27% sequential improvement, representing the highest quarterly sales in its recent history.

Advanced Enzyme Technologies Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 27 Apr 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 May 2026, providing investors with the latest insights into its performance and valuation.

Surging past its previous peak, Advanced Enzyme Technologies Ltd touched a fresh 52-week high of Rs 370.9 on 8 May 2026, marking a significant milestone in its price momentum. This advance comes amid a backdrop of strong technical signals that have aligned to propel the stock higher despite a broadly subdued market environment.

With a decisive surge to Rs 366.95 on 5 May 2026, Advanced Enzyme Technologies Ltd has reached a fresh 52-week high, marking a 45.6% rise from its low of Rs 251.90 over the past year. This milestone reflects a sustained momentum driven by a confluence of technical indicators aligning favourably despite a broadly subdued market backdrop.

Advanced Enzyme Technologies Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in technical indicators and market returns despite flat financial results. The upgrade, effective from 27 April 2026, is driven primarily by a shift in technical trends, valuation considerations, and a stable financial position, positioning the small-cap pharmaceutical company for cautious optimism among investors.

Advanced Enzyme Technologies Ltd has witnessed a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish outlook. This change is underscored by a robust 10.56% gain in the stock price on 28 Apr 2026, signalling renewed investor interest amid mixed technical indicator signals and a favourable comparison against benchmark indices.

The Sensex advanced 0.39% on 27 Apr 2026, yet Advanced Enzyme Technologies Ltd outpaced the broader market with a 7.09% gain, reaching an intraday high of Rs 320.65. This 5.64 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector peers signals a distinctly stock-specific rally rather than a market-wide lift.

Advanced Enzyme Technologies Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 21 Nov 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 26 April 2026, providing investors with an up-to-date perspective on the stock’s fundamentals, valuation, financial trends, and technical outlook.